Integrating Patient Preferences in Nonclinical Assessment of Immunomodulatory Therapies – Shifting the Paradigm
Immune-related adverse events (irAEs) are one of the leading causes affecting success rates of immunomodulatory …
This category contains more general project news, including information about project meetings and events, stakeholder workshops and more broader online seminars, general project publications and much more.
Immune-related adverse events (irAEs) are one of the leading causes affecting success rates of immunomodulatory …
Over two, well attended sessions in September 2021, the topic of cytokine release assays (CRA) …
The upcoming imSAVAR Stakeholder Workshop: Integrating Patient Preferences in Nonclinical Assessment of Immunomodulatory Therapies – …
The imSAVAR consortium selected four modes of action (MoAs)—CAR Ts, CPIs, BiTEs and IL-2 TREGs—needing …
The advances in cancer immunotherapy come with several roadblocks limiting their widespread use and their …